CLOVER HEALTH INVESTMENTS CO (CLOV) Institutional Buying Activity
Institutional investors tracked by InsiderSet increased exposure to CLOVER HEALTH INVESTMENTS CO (CLOV) during the quarter ended March 31, 2026 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.
Several hedge funds and long-term asset managers reported increases in CLOV exposure during the latest reporting period based on SEC Form 13F filings.
Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward CLOVER HEALTH INVESTMENTS CO (CLOV). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.
No data available.
Frequently asked questions about CLOV activity
Which institutional owners are buying CLOV?
Institutional owners buying CLOV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CLOV activity?
"Buy" means an investor increased their reported position in CLOV compared to the prior reporting period. This reflects growing exposure to CLOVER HEALTH INVESTMENTS CO (CLOV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CLOV increasing?
Institutional interest in CLOV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.